MYRIAD GENETICS INC
10-Q, EX-27.1, 2000-11-14
COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH
Previous: MYRIAD GENETICS INC, 10-Q, 2000-11-14
Next: SOURCE MEDIA INC, 10-Q, 2000-11-14



<TABLE> <S> <C>

<PAGE>
<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE
CONDENSED UNAUDITED CONSOLIDATED STATEMENTS OF OPERATIONS AND CONDENSED
CONSOLIDATED BALANCE SHEETS AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO
SUCH FINANCIAL STATEMENTS.
</LEGEND>

<S>                             <C>
<PERIOD-TYPE>                                    3-MOS
<FISCAL-YEAR-END>                          JUN-30-2001
<PERIOD-START>                             JUL-01-2000
<PERIOD-END>                               SEP-30-2000
<CASH>                                      58,631,551
<SECURITIES>                                45,916,925
<RECEIVABLES>                                2,948,094
<ALLOWANCES>                                   180,000
<INVENTORY>                                          0
<CURRENT-ASSETS>                            90,367,061
<PP&E>                                      22,352,293
<DEPRECIATION>                              10,588,219
<TOTAL-ASSETS>                             122,227,963
<CURRENT-LIABILITIES>                       24,029,335
<BONDS>                                              0
                          223,268
                                          0
<COMMON>                                             0
<OTHER-SE>                                  97,975,360
<TOTAL-LIABILITY-AND-EQUITY>               122,227,963
<SALES>                                      3,050,009
<TOTAL-REVENUES>                            10,819,260
<CGS>                                        1,305,362
<TOTAL-COSTS>                               14,039,549
<OTHER-EXPENSES>                               248,465
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                   0
<INCOME-PRETAX>                            (2,070,461)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                        (2,070,461)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                               (2,070,461)
<EPS-BASIC>                                     (0.09)
<EPS-DILUTED>                                   (0.09)




</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission